Clinical Trial Update: Local Study of Akatinol Memantine in VaD in Russia [Phase 3]

View source ↗

Summary

Phase 3 trial update for Akatinol Memantine in vascular dementia in Russia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vascular Dementia

Drugs mentioned

• Akatinol Memantine (memantine)

Snippet

Sponsor: Merz Pharmaceuticals GmbH | Conditions: Vascular Dementia | Phase 3 | Status: COMPLETED